索米妥昔单抗治疗叶酸受体α阳性铂耐药复发卵巢癌的成本-效果分析
吴义来, 何银梅, 栾家杰, 张文
Cost-effectiveness analysis of mirvetuximab soravtansine in treating recurrent， platinum-resistant， folate receptor α-positive ovarian cancer
WU Yilai, HE Yinmei, LUAN Jiajie, ZHANG Wen
中国医院药学杂志
.
2025, (21): 2479
-2484
.
DOI: 10.13286/j.1001-5213.2025.21.09
